As of April 19, 2025, Kezar Life Sciences (KZR) has a market cap of $30.392 million USD. According to our data, Kezar Life Sciences is ranked No.8355 in global market value.
Year | Market Cap | %Change |
---|---|---|
Apr 19, 2025 | $30.39 M |
-38.01%
|
Dec 31, 2024 | $49.03 M |
-29.26%
|
Dec 29, 2023 | $69.31 M |
-86.51%
|
Dec 30, 2022 | $0.51 B |
-57.89%
|
Dec 31, 2021 | $1.22 B |
220.31%
|
Dec 31, 2020 | $0.38 B |
30.17%
|
Dec 31, 2019 | $0.29 B |
-83.01%
|
Dec 31, 2018 | $1.72 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() Aurinia Pharmaceuticals
AUPH
|
$1.06 B |
0.000 M
|
![]() Canada
|
![]() Corbus Pharmaceuticals
CRBP
|
$73.76 M |
0.000 M
|
![]() USA
|
![]() Equillium
EQ
|
$16.88 M |
0.089 M
|
![]() USA
|
![]() Gossamer Bio
GOSS
|
$0.19 B |
-0.114 M
|
![]() USA
|
![]() Immunovant
IMVT
|
$2.57 B |
-0.000 M
|
![]() USA
|
![]() Kiniksa Pharmaceuticals
KNSA
|
$1.47 B |
0.619 B
|
|
![]() Morphic Therapeutic
MORF
|
$2.86 B |
0.000 M
|
![]() USA
|
![]() Omeros Corporation
OMER
|
$0.39 B |
-0.000 M
|
![]() USA
|
![]() Rigel Pharmaceuticals
RIGL
|
$0.30 B |
0.000 M
|
![]() USA
|
![]() TG Therapeutics
TGTX
|
$6.02 B |
-0.000 M
|
![]() USA
|
Market Cap | = | KZR Stock Price | * | KZR Shares Outstanding |
= | $4.16 | * | 7.31 M | |
= | $30.39 M |